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Objective: Takotsubo cardiomyopathy is a cardiac syndrome with an acute onset deﬁned by chest
symptoms and ST segment elevation on electrocardiograms. Takotsubo cardiomyopathy is sometimes
misdiagnosedasacutemyocardial infarction (AMI). Thereforeanon-invasivediagnosticmethod isneeded
to be established for setting up appropriate strategies. The purpose of this study was to detect myocar-
dial metabolic abnormalities and to determine the diagnostic usefulness of 123I-beta-methy-iodophenyl
pentadecanoic acid (123I-BMIPP) imaging in patients with takotsubo cardiomyopathy.
Methods and results:Weexamined16patientswith takotsubo cardiomyopathy and12withAMI in the left
anterior descending artery. All patients were studied with resting 123I-BMIPP imaging. Total defect score
(TDS) of 123I-BMIPP and perfusion were semi-quantitatively determined with single-photon emission
computed tomography (SPECT) imaging using a 17-segment 5-point model. TDS of 123I-BMIPP were
4.8±2.7 in patients with Takotsubo cardiomyopathy and 22.4±10.7 in AMI. The ratio of summed BMIPP
defect score of non-apical to apical segments in Takotsubo cardiomyopathy was smaller than that of
the patients with AMI (0.1±0.1 vs. 1.1±0.7, p<0.0001), indicating that 123I-BMIPP abnormalities were
exclusively observed the in apical area. The ratio of summed perfusion defect scores of non-apical to
apical segments in takotsubo cardiomyopathy did not differ signiﬁcantly from that of AMI (0.52±0.6
vs. 0.57±0.3, p=NS). Summed BMIPP defect score in the apical area of takotsubo cardiomyopathy was
larger than that of perfusion defect score (3.9±2.7 vs. 1.8±1.8, p=0.04).
Conclusion: Impaired metabolic metabolism exclusively in the apical region was observed by 123I-BMIPP
SPECT images in takotsubo cardiomyopathy. These typical metabolic SPECT features of the disease can
be utilized on differential diagnosis of takotsubo cardiomyopathy.
© 2013 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.ntroduction
Reports have described a reversible left ventricular dysfunc-
ionwith symptoms similar to those of acutemyocardial infarction
AMI), but without coronary artery lesions even during the acute
hase with ST segment elevation [1,2]. This dysfunction, known as
takotsubo cardiomyopathy’ (transient left ventricular apical bal-
ooning), characteristically resolves within a few weeks [3,4]. The
apanese word “takotsubo” means an octopus ﬁshing pot with a
ound bottom and a narrow neck. Patients with takotsubo car-
iomyopathy are sometimes misdiagnosed as having AMI of the
∗ Correspondingauthorat:DepartmentofNuclearMedicine,KanazawaUniversity
ospital, 13-1 Takara-machi, Kanazawa 920-8641, Japan. Tel.: +81 76 265 2333;
ax: +81 76 234 4257.
E-mail address: smatsuo@nmd.m.kanazawa-u.ac.jp (S. Matsuo).
914-5087/$ – see front matter © 2013 Japanese College of Cardiology. Published by Else
ttp://dx.doi.org/10.1016/j.jjcc.2013.10.019left anterior descending (LAD) coronary artery [5–7]. Coronary
angiography is conducted to exclude coronary artery disease [8].
A noninvasive diagnostic method is needed to set up appropriate
strategies in patients with takotsubo cardiomyopathy. Further-
more, the origin anddetailed clinical features of this disease remain
unknown [9].
Myocardial fatty acid metabolic imaging with 123I-beta-methy-
iodophenyl pentadecanoic acid (BMIPP) has been used for the
evaluation of various cardiac diseases such as ischemic heart dis-
ease [10,11], and dilated or hypertrophic cardiomyopathies [12].
Several reports showed that 123I-BMIPP was superior to perfusion
imaging for detectingmyocardial damage of patientswith ischemic
heart disease or cardiomyopathy [12,13]. However, few studies
have reported in detail on the diagnosis and the metabolism in
takotsubo cardiomyopathy in comparison with AMI [14,15].
We analyzed clinical and radionuclide imaging data, includ-
ing metabolic imaging in patients with takotsubo cardiomyopathy
vier Ltd. All rights reserved.
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n an attempt to detect myocardial metabolic abnormalities and
o determine the diagnostic usefulness of 123I-BMIPP imaging in
atients with takotsubo cardiomyopathy.
ethods
atient characteristics
The subjects included 16 patients with takotsubo cardiomy-
pathy and 12 patients with AMI of the LAD. All patients were
dmitted to our hospital and underwent 123I-BMIPP scintigraphy
uring hospitalization. Study subjects had takotsubo-like left ven-
ricular (LV) dysfunction, and were hospitalized at our university
ospital. All patients were clinically diagnosed with takotsubo-
ike LV dysfunction according to the following criteria: (1) LV wall
otion abnormality mainly at the apex; (2) sudden occurrence of
eart failure; (3) absence of coronary artery disease on coronary
ngiography; and (4) complete normalization of the LV dysfunc-
ionwithin a fewweeks [13]. For comparison, the subjects included
atients with AMI who were admitted to hospital with a diagnosis
f ﬁrst anterior AMI. Each patient successfully underwent percuta-
eous coronary intervention and achieved good coronary ﬂow. All
f the patients had culprit lesions in the proximal LAD, and only
atients with single-vessel disease were enrolled in this study.
The study was summarized retrospectively and was approved
y our institutional Ethics Committee.
23I-BMIPP imaging
123I-BMIPP at adoseof 111MBqwas injected slowly through the
ntecubital vein at rest after a 3-h fast. The single-photon emission
omputed tomography (SPECT) data were obtained approximately
0min after injection. A wide ﬁeld-of-view dual-head detector
amera (Symbia T6, Siemens Co., Tokyo, Japan) equipped with a
ow-medium-energy, general-purpose collimator without X-ray-
ased attenuation correction was used [16]. Thirty-two images
ere obtained for 40 s in each6◦ interval. Image reconstructionwas
erformed with a nuclear medicine computer system (Siemens)
y means of a ﬁltered back-projection algorithm without attenua-
ioncorrection. Short-axis, thevertical long-axis, and thehorizontal
ong-axis slices, each 6mm thick were reconstructed.yocardial perfusion imaging
Myocardial perfusion study was performed at rest
sing 740 MBq of 99mTc-labeled sestamibi or tetrofosmin.
ig. 1. Left ventricular segmentation. Diagrammatic presentation of a circumferential pola
asal inferoseptal; 4, basal inferior; 5, basal inferolateral; 6, basal anterolateral; 7,mid ante
2, mid anterolateral; 13, apical anterior; 14, apical septal; 15, apical inferior; 16, apical la
CA, right coronary artery.diology 64 (2014) 49–56
Electrocardiography-gated SPECT images were acquired with a
64×64 matrix, 6◦ step, and 360◦ rotation.
Data analysis
Segmental uptake of 123I-BMIPP was quantiﬁed using semi-
quantitative scores by QPS software (Cedars Sinai Medical Center,
LA, USA) and was conﬁrmed by two experienced nuclear car-
diologists. A 17-segment model of left ventricle was used with
a 5-point scale (0 =normal uptake, 1 =mildly-reduced uptake,
2 =moderately-reduced uptake, 3 = severely-reduced uptake, and
4=no uptake) (Fig. 1). The sum of 17 segments was deﬁned as
total defect score (TDS). BMIPP TDS were calculated by adding the
scores of 17 segments on the 123I-BMIPP rest images, reﬂecting
the severity of impaired fatty acid metabolism. The perfusion TDS
was similarly calculated for perfusion studies, reﬂecting the sever-
ity of impaired myocardial perfusion. Apical summed defect score
was deﬁned as summed score of segments 13–17, and non-apical
summed defect score as summed score of segments 1–12. A mis-
match score between perfusion and 123I-BMIPP was calculated by
subtracting perfusion TDS from BMIPP TDS. A mismatch between
perfusion and BMIPP was deﬁned to exist when mismatch score is
2 or more.
Statistical analysis
All values are presented as mean values± standard deviation.
To examine differences between groups, t-test and non-parametric
analysis using Wilcoxon/Kruskal–Wallis test were used to com-
pare the data and p-values of less than 0.05 were considered to
be signiﬁcant.
Results
Clinical characteristics
Table 1 shows the clinical characteristics of the study sub-
jects with takotsubo cardiomyopathy and AMI. Clinical features on
admission in patients with takotsubo cardiomyopathy were as fol-
lows. In a group of 16 patients with takotsubo cardiomyopathy, 8
were men and the mean age of the group was 72±3 years, ran-
ging in age from 55 to 85 years. In 12 patients with AMI, 8 were
men and the mean age was 67±3 years, ranging from 44 to 91
years. Plasma levelsofpeakcreatininephosphokinaseonadmission
in patients with takotsubo cardiomyopathy were 261±337 IU/L,
and 2116±1861 IU/L in AMI. The BMIPP studies were performed
rplot of 17 segmentmodel of left ventricle: 1, basal anterior; 2, basal anteroseptal; 3,
rior; 8,mid anteroseptal; 9,mid inferoseptal; 10,mid inferior; 11,mid inferolateral;
teral; and 17, apex. LAD, left anterior descending artery; LCX, left circumﬂex artery;
S. Matsuo et al. / Journal of Card
Table 1
Characteristics of study subjects.
Takotsubo cardiomyopathy
n=16
AMI
n=12
p
Age (years) 72±3 67±3 NS
Male gender 8 (50%) 8 (67%) NS
Coronary risk factors
Hypertension 7 (44%) 5 (42%) NS
Diabetes mellitus 2 (13%) 3 (19%) NS
Dyslipidemia 1 (6%) 6 (50%) 0.005
Current smoking 4 (25%) 5 (42%) NS
Peak CPK (IU/L) 261±337 2116±1861 0.0006
Cardiac medications
Aspirin 1 (6%) 5 (42%) 0.002
Beta-blocker 3 (19%) 4 (33%) NS
ACEIs or ARB 4 (25%) 5 (42%) NS
Nitrates 1 (6%) 0 (0%) NS
Any of the above 9 (56%) 7 (58%) NS
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cMI, acute myocardial infarction; NS, not signiﬁcant; CPK, creatinine phosphoki-
ase; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor
locker.
1.1±2.1 days from admission in patients with takotsubo car-
iomyopathy and 14.6±2.5 days in patients with AMI.
23I-BMIPP SPECT images
BMIPP TDS in patients with takotsubo cardiomyopathy was
.8±2.7, and 22.4±10.7 in AMI. 123I-BMIPP defect score of the 17
egments of left ventricle in patients with takotsubo cardiomyopa-
hy and AMI are shown in Table 2.
Fig. 2 depicts polar map of BMIPP and perfusion imaging, and
oronary angiogram in a case of a 66-year-old male patient with
akotsubo cardiomyopathy.
Apical summed defect scores were 3.9±2.7 in takotsubo car-
iomyopathy, and 10.8±5 in AMI (Table 2). Non-apical summed
efect scores were 1.1±2.1 in takotsubo cardiomyopathy, and
1.7±7.1 in AMI. BMIPP summed defect scores of apical and non-
pical segments were compared and the ratio of BMIPP non-apical
egment to apical segment was calculated. The ratio of apical and
able 2
omparison of 123I-BMIPP SPECT defect between takotsubo cardiomyopathy and
MI of left anterior descending coronary artery in 17 segments of left ventricle.
Takotsubo
cardiomyopathy
AMI p
Non-apical area 1.1 ± 2.1 11.7 ± 7.1 <0.0001
1. Basal anterior 0.1 ± 0.3 1.2 ± 0.3 0.008
2. Basal anteroseptal 0.1 ± 0.3 1.2 ± 0.3 0.02
3. Basal inferoseptal 0.1 ± 0.3 1.1 ± 0.3 0.02
4. Basal inferior 0.0 ± 0.1 0.3 ± 0.2 NS
5. Basal inferolateral 0.0 ± 0.0 0.0 ± 0.0 NS
6. Basal anterolateral 0.0 ± 0.0 0.1 ± 0.1 NS
7. Mid anterior 0.1 ± 0.2 2.8 ± 0.2 <0.0001
8. Mid anteroseptal 0.1 ± 0.2 2.8 ± 0.2 <0.0001
9. Mid inferoseptal 0.1 ± 0.2 1.0 ± 0.2 0.002
10. Mid inferior 0.1 ± 0.1 0.4 ± 0.2 0.2
11. Mid inferolateral 0.2 ± 0.2 0.3 ± 0.2 NS
12. Mid anterolateral 0.0 ± 0.2 0.7 ± 0.2 0.04
Apical area 3.9 ± 2.7 10.8 ± 4.9 <0.0001
13. Apical anterior 0.4 ± 0.2 3.0 ± 0.2 <0.0001
14. Apical septal 0.5 ± 0.2 2.8 ± 0.3 <0.0001
15. Apical inferior 0.6 ± 0.3 0.8 ± 0.3 NS
16. Apical lateral 0.8 ± 0.3 1.1 ± 0.4 NS
17. Apex 1.6 ± 0.8 3.0 ± 0.3 0.0002
BMIPP total defect score 4.8 ± 2.7 22.4 ± 10.7 <0.0001
MIPP, 123I-beta-methy-iodophenyl pentadecanoic acid; SPECT, single-photon
mission computed tomography; AMI, acute myocardial infarction; NS, not signiﬁ-
ant.iology 64 (2014) 49–56 51
non-apical summedBMIPP defect score of takotsubo cardiomyopa-
thy was smaller than that of the patients with AMI (0.1±0.1 vs.
1.0±0.1, p<0.0001) (Fig. 3). 123I-BMIPP showed reduced uptake
exclusively in the apical segments of the myocardium, indicating
impairment of metabolic abnormalities in patients with takotsubo
cardiomyopathy.
99mTc perfusion images
99mTc perfusion SPECT imaging was performed in 13 out of
16 subjects with takotsubo cardiomyopathy and all 12 patients
with AMI. The interval between the two studies was 3.7±3.7 days
and 3.2±2.3 days in patients with takotsubo cardiomyopathy,
and AMI, respectively. The perfusion TDS in patients with takot-
subo cardiomyopathy was signiﬁcantly lower than in those with
AMI (2.6±2.9 vs. 13.3±9.2, p<0.0001). No signiﬁcant difference
was observed in perfusion summed defect score between apical
area and non-apical area in takotsubo cardiomyopathy (1.8±1.8
vs. 0.9±1.4, p=NS) and in AMI (8.7±5.2 vs. 4.7±4.5, p=NS).
The ratio of summed perfusion defect scores of apical and non-
apical segment scores of takotsubo cardiomyopathy did not differ
signiﬁcantly from that of AMI (0.52±0.6 vs. 0.57±0.3, p=NS)
(Fig. 4).
Comparison of perfusion SPECT data between takotsubo
cardiomyopathy and AMI in 17 segments of left ventri-
cle is shown in Table 3. BMIPP defect score in apical
area of takotsubo cardiomyopathy was larger than that of
perfusion defect score (3.9±2.7 vs. 1.8±1.8, p=0.04). The mis-
match between perfusion and 123I-BMIPP was larger in patients
with AMI than in those with takotsubo cardiomyopathy (9.1±7.5
vs. 2.7±1.5 in patients who underwent both BMIPP and per-
fusion, p=0.006). Fig. 4 shows the location of the mismatched
area between BMIPP and perfusion scan in patients with takot-
subo cardiomyopathy and AMI in 17 segments of left ventricle. Six
mismatched areas (123I-BMIPP defect larger than perfusion defect)
were observed in patients with takotsubo cardiomyopathy and 50
mismatched areas inAMI. In patientswith takotsubo cardiomyopa-
thy,mismatches between perfusion and 123I-BMIPPwere observed
exclusively in the apical lesion, including apical lateral, apical infe-
rior, and apex. In patients with AMI, a mismatch in the apical
segment was observed in 12 out of 50 segments (24%).
Discussion
Our study shows the characteristics of regional pattern of
metabolic abnormalities in patients with takotsubo cardiomyopa-
thy differs from that of acute myocardial infarction. Metabolic
abnormalities in takotsubo cardiomyopathy are found exclu-
sively in the apical portion, which is clearly different from the
defects on myocardial perfusion scan. Such information of cardiac
metabolic 123I-BMIPP imaging can be used to detect myocar-
dial injury and be used as an important tool to diagnose the
disease.
Previous reports stated that takotsubo cardiomyopathy resem-
bles an AMI [17–19]. About 1% of all suspected AMIs were
diagnosed as takotsubo cardiomyopathy [2,14]. Since electro-
cardiographic abnormalities resemble AMI, the patients with
takotsubo cardiomyopathy are sometimes misdiagnosed. There-
fore, the diagnosis of takotsubo cardiomyopathy continues to be a
challenge, andevaluationof the severity of thediseasebymetabolic
imaging has not been fully established.Fatty acid metabolism and ischemic heart disease
Ischemia may cause a reduction of fatty acid utilization and
shift from fatty acid to glucose utilization in the myocardium.
52 S. Matsuo et al. / Journal of Cardiology 64 (2014) 49–56
Fig. 2. Cardiac single-photon emission computed tomography image using 123I-beta-methy-iodophenyl pentadecanoic acid (123I-BMIPP) (upper left) and 99mTc-sestamibi
(upper right) in a 66-year-old male patient with takotsubo cardiomyopathy. Discordant123I-BMIPP uptake less than perfusion uptake in the apex is shown. Yellow arrow
shows decreased uptake of BMIPP in apical area. In the acute phase left ventriculography showed apical akinesis and basal normokinesis (ED, end-diastole; ES, end-systole).
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aoronary angiography revealed no stenotic legion (RCA, right coronary artery; LCA
he reader is referred to the web version of the article.)
23I-BMIPP is metabolized in the myocardium and its metabolism
s closely related to myocardial carbohydrate utilization. There-
ore, we assumed that the metabolic abnormalities were detected
n the cellular level or as a microcirculation abnormality on
23I-BMIPP imaging. In ischemic heart disease Tamaki et al.
rst described discordant 123I-BMIPP uptake less than thallium
ptake in 17 of 28 patients with myocardial infarction [10].
uch discordant 123I-BMIPP uptake was observed more often in
reas of acute rather than chronic myocardial infarction (59% atoronary artery). (For interpretation of the references to color in this ﬁgure legend,
<4 weeks versus 31% at >4 weeks after onset), and more often
in areas supplied by revascularized arteries than in areas sup-
plied by non-revascularized arteries (74% versus 28%). A recent
study showed that the perfusion-metabolism information could
improve the risk stratiﬁcation of the patients with coronary artery
disease [20].
One of themajor applications of 123I-BMIPP SPECT is the diagno-
sis of acute coronary syndrome in theuseof emergencydepartment
practice. The imaging could add incremental diagnostic value to
S. Matsuo et al. / Journal of Card
Fig. 3. Comparison of defect score between apical and non-apical segments in
takotsubo cardiomyopathy or acute myocardial infarction (AMI). (A) The ratio of
123I-beta-methy-iodophenyl pentadecanoic acid (BMIPP) summed defect score of
non-apical segments to apical segments is shown. (B) The ratio of perfusion defect
score of non-apical segments to the apical segments is shown. Green bar and blue
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tics of metabolic abnormalities associated with ischemic memory.ars are mean value and standard deviation, respectively.
he initial clinical information. Kawai et al. reported a sensitivity
f 123I-BMIPP imaging of 74% to detect obstructive coronary steno-
is or provocative spasm, when it was performed within 3 days of
ymptoms [21]. In addition cardiac metabolic abnormalities were
een inmany patients with coronary spasm, and the imaging could
e used to monitor the response to treatment [22]. These ﬁnd-
ngs were conﬁrmed by a multicenter study in the USA [23]. This
oninvasive scintigraphic method is widely applied for diagnosing
cute coronary syndrome and might represent the most suitable
pproach to investigate cardiac metabolism especially in the early
eriod on admission without any risk of the examination itself.
hesemicrovascular circulation abnormalities couldbedetectedby
etabolic 123I-BMIPP imaging in the resting state. Reduced coro-
ary ﬂow is sometimes observed after emergency angiography
ithout coronary stenosis, which is termed as no-reﬂow phe-
omenon. Therefore, coronary spasm including epicardial coronary
rtery and coronary micro-vessels cannot be ruled out as one of
hemechanisms causingmyocardial ischemia [24]. Less 123I-BMIPP
ptake than perfusion is called “mismatched myocardium,” which
ndicates the presence of ischemic and jeopardized myocardium
25]. The combined imagingwith 123I-BMIPP and perfusionmay beiology 64 (2014) 49–56 53
used to identify high-risk subjects among patients with chest pain
syndrome [21].
Fatty acid metabolism in takotsubo cardiomyopathy
123I-BMIPP in this study of patients with takotsubo cardiomy-
opathy showed reduced uptake in the apical segment of the
myocardium, indicating impairment of fatty acid metabolism in
non-infarcted myocardium. Our study showed mismatched areas
in sub-acute phase in takotsubo cardiomyopathy in accordance
with previous reports [13,14]. The mismatch may indicate jeopar-
dized but viablemyocardium, reﬂecting transient ischemic damage
or metabolically stunned myocardium. The area of metabolic
abnormality in the apical segment was relatively smaller than that
of AMI in LAD lesions. There are few reports on the fatty acid
metabolism of takotsubo cardiomyopathy. Kurisu et al. reported
the time course of myocardial perfusion and fatty acid metabolism
in patientswith takotsubo-like left ventricular dysfunction [13,14].
Mismatched area observed in the acute phase of the disease, was a
similar ﬁnding to stunnedmyocardium. Ito et al. reported myocar-
dial metabolic abnormality combined with other nuclear tracers,
which resembled that of AMI, suggesting stunned myocardium or
impaired microcirculation as a causative mechanism of Takotsubo
cardiomyopathy [15]. Regional semi-quantitative analysis in this
study revealed that the cardiac metabolic abnormalities detected
by 123I-BMIPP imaging are only in the apical area, which is one of
the typical metabolic SPECT features of takotsubo cardiomyopa-
thy.
Although the pathogenesis of takotsubo cardiomyopathy is
undetermined, multivessel spasm, coronary microvascular dys-
function, or catecholamine toxicity after a severe emotional trigger,
surgical, or medical procedure has been proposed to explain
the provocative pathophysiology of takotsubo cardiomyopathy
[26–29]. One study reported that coronary spasm was observed in
about 28.6% of the patients with takotsubo cardiomyopathy [30].
Increased sympathetic tone from mental stress possibly causes
microvascular spasm, and induces coagulation and formation and
dissolution of ﬁbrin. Recurrence occurs in about 11.4% of patients
with takotsubo cardiomyopathy during 4-year observation with
no evidence of coronary progression [31]. Apical metabolic abnor-
malities may in part be explained by a metabolic disorder in the
myocardium subsequent to a catecholamine surge or microvascu-
lar spasm. With the hypothesis of metabolic stunned myocardium
as a causative mechanism of takotsubo cardiomyopathy, BMIPP
imaging appears to be one of the most speciﬁc diagnostic tech-
niques.
18F-ﬂuorodeoxyglucose (FDG) positron emission tomography
(PET) study using glucose-loaded method can measure glu-
cose utilization in the myocardium. Studies with 18F-FDG-PET
showed reduced apical uptake in patients with takotsubo car-
diomyopathy, which is a similar result to the patients with
myocardial infarction [32–34]. The studies suggested that the glu-
cose metabolism was suppressed especially in the apical segment
of stunnedmyocardium, suggesting preserved oxygenmetabolism
[35].
Diagnostic value of 123I-BMIPP SPECT
We assume that the present study provides us a clue to
differentiate diagnosis in the early time of admission between
takotsubo cardiomyopathy and acute coronary syndrome, since
takotsubo cardiomyopathy could be recognized by the characteris-Previous reports suggested that abnormalities in resting per-
fusion imaging in sub-acute phase were not obvious [36]. Our
study showed the metabolic abnormality was larger than that of
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erfusion. Thereforemetabolic imagingwith 123I-BMIPPwouldbea
etter indicator of myocardial damage than perfusion study. Stress
yocardial perfusion scintigraphy with exercise and/or vasodila-
ory drugs may help diagnose and stratify risk in patients with
hest pain. However, stress test is not suitable or recommended
or the patients with chest pain and unstable angina. The addition
f 123I-BMIPP imaging information to the initial available clinical
ata provides incremental value for the early diagnosis of takot-
ubo cardiomyopathy, potentially allowing determination of the
resenceorabsenceof takotsubocardiomyopathy tobemademuch
arlier in the evaluation process [37]. 123I-BMIPP imagingmight be
ble to predict therapeutic effects and set up appropriate strategies
n patients with suspected acute coronary syndrome or takotsubo
ardiomyopathy.
ig. 4. Location of mismatched area between 123I-beta-methy-iodophenyl pentadecanoi
a) and acute myocardial infarction (AMI) (b). Mismatched segments were observed excludiology 64 (2014) 49–56
Study limitations
The present study had several limitations. First this was
a single-center, retrospective, observational study. Second, the
small number of patients investigated requires further intensive
studies to conﬁrm its usefulness in determining the progno-
sis in takotsubo cardiomyopathy. Third, the different days of
BMIPP acquisition from the admission between takotsubo car-
diomyopathy and AMI may affect the size of mismatched area.
Fourth, we did not perform repeated 123I-BMIPP study. Although
beta-blockers and calcium channel blockers may prevent stress-
induced cardiac dysfunction [38,39], the usefulness to assess
the response to therapy needs to be evaluated in further
studies.
c acid (123I-BMIPP) and perfusion scan in patients with takotsubo cardiomyopathy
sively in the apical area in takotsubo cardiomyopathy.
S. Matsuo et al. / Journal of Card
Table 3
Comparison of perfusion defect score between takotsubo cardiomyopathy and AMI
of left anterior descending coronary artery in 17 segments of left ventricle.
Takotsubo
cardiomyopathy
AMI p
Non-apical area 0.9 ± 1.4 4.7 ± 4.5 0.002
1. Basal anterior 0.0 ± 0.2 0.6 ± 0.2 0.03
2. Basal anteroseptal 0.07 ± 0.2 0.3 ± 0.2 NS
3. Basal inferoseptal 0.0 ± 0.06 0.08 ± 0.06 NS
4. Basal inferior 0.08 ± 0.06 0.0 ± 0.06 NS
5. Basal inferolateral 0.0 ± 0.0 0.0 ± 0.0 NS
6. Basal anterolateral 0.0 ± 0.0 0.0 ± 0.0 NS
7. Mid anterior 0.08 ± 0.2 1.4 ± 0.3 0.0008
8. Mid anteroseptal 0.15 ± 0.2 1.0 ± 0.2 0.02
9. Mid inferoseptal 0.08 ± 0.1 0.25 ± 0.1 NS
10. Mid inferior 0.31 ± 0.1 0.17 ± 0.1 NS
11. Mid inferolateral 0.08 ± 0.07 0.08 ± 0.08 NS
12. Mid anterolateral 0.08 ± 0.3 0.75 ± 0.3 NS
Apical area 1.8 ± 1.8 8.7 ± 5.2 0.0005
13. Apical anterior 0.23 ± 0.3 2.3 ± 0.3 0.0005
14. Apical septal 0.23 ± 0.3 1.7 ± 0.3 0.003
15. Apical inferior 0.23 ± 0.2 0.8 ± 0.2 0.06
16. Apical lateral 0.23 ± 0.3 1.5 ± 0.3 0.001
17. Apex 0.77 ± 0.3 2.5 ± 0.3 0.001
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[
[Perfusion total defect score 2.6 ± 2.9 13.3 ± 9.2 <0.0001
MI, acute myocardial infarction; NS, not signiﬁcant.
onclusion
Metabolic abnormality exclusively in the apical region was
bserved in takotsubo cardiomyopathy. These results demonstrate
hat cardiac metabolic 123I-BMIPP imaging can detect myocardial
njury and may be used as a tool to diagnose the disease. These
ypical metabolic SPECT features of the disease can be utilized on
ifferential diagnosis and for evaluating the severity or the risk of
akotsubo cardiomyopathy.
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